Cholangiocarcinoma Market revenue to hit USD 1.3 Billion by 2036, says Research Nester
December 07, 2023 06:30 ET
|
Research Nester
New York , Dec. 07, 2023 (GLOBE NEWSWIRE) -- The global cholangiocarcinoma market size is projected to grow at a CAGR of over 4% from 2024 to 2036. The market is expected to garner a revenue of USD...
Topin & Associates Has Been Selected by Myriad Genetics, Inc., to Market OnDose(R) Dose Optimization Technology
May 26, 2011 08:30 ET
|
Topin & Associates, Inc.
CHICAGO, May 26, 2011 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., has selected Topin & Associates (topin.com) to support the ongoing marketing of OnDose Dose Optimization Technology to the oncology...